<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900420-0164</DOCNO><DOCID>900420-0164.</DOCID><HL>   Shell Oil Mulls Selling a Unit</HL><DATE>04/20/90</DATE><SO>WALL STREET JOURNAL (J), PAGE A5</SO><CO>   RD SC</CO><IN>TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)</IN><LP>   HOUSTON -- Shell Oil Co., a unit of Royal Dutch/ShellGroup, said that it is considering selling Triton BiosciencesInc., its wholly-owned health-care subsidiary, which developspharmaceuticals and diagnostics for serious illnesses, andthat it retained Morgan Stanley andamp; Co. of New York asfinancial adviser for the project.   Shell said it views Triton as &quot;a successful health-careoperation,&quot; but decided &quot;after extensive review . . . thatTriton is not sufficiently related to {Shell's} principalpetrochemical business to retain it for the long term.&quot;Triton has about 300 employees in Alameda, Calif.</LP><TEXT/></DOC>